153 related articles for article (PubMed ID: 10966497)
1. Mechanism of the inhibitory effect of OPB-9195 [(+/-)-2-isopropylidenehydrazono-4-oxo-thiazolidin-5-yla cetanilide] on advanced glycation end product and advanced lipoxidation end product formation.
Miyata T; Ueda Y; Asahi K; Izuhara Y; Inagi R; Saito A; VAN Ypersele DE Strihou C; Kurokawa K
J Am Soc Nephrol; 2000 Sep; 11(9):1719-1725. PubMed ID: 10966497
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product: carbonyl stress in uremia.
Miyata T; Ueda Y; Yamada Y; Izuhara Y; Wada T; Jadoul M; Saito A; Kurokawa K; van Ypersele de Strihou C
J Am Soc Nephrol; 1998 Dec; 9(12):2349-56. PubMed ID: 9848790
[TBL] [Abstract][Full Text] [Related]
3. 2-Isopropylidenehydrazono-4-oxo-thiazolidin-5-ylacetanilide (OPB-9195) treatment inhibits the development of intimal thickening after balloon injury of rat carotid artery: role of glycoxidation and lipoxidation reactions in vascular tissue damage.
Miyata T; Ishikawa S; Asahi K; Inagi R; Suzuki D; Horie K; Tatsumi K; Kurokawa K
FEBS Lett; 1999 Feb; 445(1):202-6. PubMed ID: 10069401
[TBL] [Abstract][Full Text] [Related]
4. Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids.
Ueda Y; Miyata T; Goffin E; Yoshino A; Inagi R; Ishibashi Y; Izuhara Y; Saito A; Kurokawa K; Van Ypersele De Strihou C
Kidney Int; 2000 Dec; 58(6):2518-24. PubMed ID: 11115086
[TBL] [Abstract][Full Text] [Related]
5. Advanced glycation and lipidoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds.
Miyata T; Horie K; Ueda Y; Fujita Y; Izuhara Y; Hirano H; Uchida K; Saito A; van Ypersele de Strihou C; Kurokawa K
Kidney Int; 2000 Jul; 58(1):425-35. PubMed ID: 10886591
[TBL] [Abstract][Full Text] [Related]
6. Inhibitor for advanced glycation end products formation attenuates hypertension and oxidative damage in genetic hypertensive rats.
Mizutani K; Ikeda K; Tsuda K; Yamori Y
J Hypertens; 2002 Aug; 20(8):1607-14. PubMed ID: 12172323
[TBL] [Abstract][Full Text] [Related]
7. Induction of 1,2-dicarbonyl compounds, intermediates in the formation of advanced glycation end-products, during heat-sterilization of glucose-based peritoneal dialysis fluids.
Schalkwijk CG; Posthuma N; ten Brink HJ; ter Wee PM; Teerlink T
Perit Dial Int; 1999; 19(4):325-33. PubMed ID: 10507813
[TBL] [Abstract][Full Text] [Related]
8. Generation of protein carbonyls by glycoxidation and lipoxidation reactions with autoxidation products of ascorbic acid and polyunsaturated fatty acids.
Miyata T; Inagi R; Asahi K; Yamada Y; Horie K; Sakai H; Uchida K; Kurokawa K
FEBS Lett; 1998 Oct; 437(1-2):24-8. PubMed ID: 9804165
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of advanced glycation end products and carbonyl compounds in patients with different conditions of oxidative stress.
Lapolla A; Reitano R; Seraglia R; Sartore G; Ragazzi E; Traldi P
Mol Nutr Food Res; 2005 Jul; 49(7):685-90. PubMed ID: 15926142
[TBL] [Abstract][Full Text] [Related]
10. Pyridoxamine, an inhibitor of advanced glycation reactions, also inhibits advanced lipoxidation reactions. Mechanism of action of pyridoxamine.
Onorato JM; Jenkins AJ; Thorpe SR; Baynes JW
J Biol Chem; 2000 Jul; 275(28):21177-84. PubMed ID: 10801874
[TBL] [Abstract][Full Text] [Related]
11. Increased carbonyl modification by lipids and carbohydrates in diabetic nephropathy.
Miyata T; Sugiyama S; Suzuki D; Inagi R; Kurokawa K
Kidney Int Suppl; 1999 Jul; 71():S54-6. PubMed ID: 10412738
[TBL] [Abstract][Full Text] [Related]
12. Accelerated formation of N epsilon-(carboxymethyl) lysine, an advanced glycation end product, by glyoxal and 3-deoxyglucosone in cultured rat sensory neurons.
Niwa H; Takeda A; Wakai M; Miyata T; Yasuda Y; Mitsuma T; Kurokawa K; Sobue G
Biochem Biophys Res Commun; 1998 Jul; 248(1):93-7. PubMed ID: 9675092
[TBL] [Abstract][Full Text] [Related]
13. Creatine plays a direct role as a protein modifier in the formation of a novel advanced glycation end product.
Miyazaki K; Nagai R; Horiuchi S
J Biochem; 2002 Oct; 132(4):543-50. PubMed ID: 12359068
[TBL] [Abstract][Full Text] [Related]
14. Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation.
Nakamura S; Makita Z; Ishikawa S; Yasumura K; Fujii W; Yanagisawa K; Kawata T; Koike T
Diabetes; 1997 May; 46(5):895-9. PubMed ID: 9133561
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms for the formation of glycoxidation products in end-stage renal disease.
Weiss MF; Erhard P; Kader-Attia FA; Wu YC; Deoreo PB; Araki A; Glomb MA; Monnier VM
Kidney Int; 2000 Jun; 57(6):2571-85. PubMed ID: 10844627
[TBL] [Abstract][Full Text] [Related]
16. An inhibitor of advanced glycation end product formation reduces N epsilon-(carboxymethyl)lysine accumulation in glomeruli of diabetic rats.
Nakamura S; Tachikawa T; Tobita K; Aoyama I; Takayama F; Enomoto A; Niwa T
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S68-71. PubMed ID: 12612956
[TBL] [Abstract][Full Text] [Related]
17. Chelating activity of advanced glycation end-product inhibitors.
Price DL; Rhett PM; Thorpe SR; Baynes JW
J Biol Chem; 2001 Dec; 276(52):48967-72. PubMed ID: 11677237
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions.
Suzuki D; Miyata T; Saotome N; Horie K; Inagi R; Yasuda Y; Uchida K; Izuhara Y; Yagame M; Sakai H; Kurokawa K
J Am Soc Nephrol; 1999 Apr; 10(4):822-32. PubMed ID: 10203367
[TBL] [Abstract][Full Text] [Related]
19. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure.
Miyata T; Wada Y; Cai Z; Iida Y; Horie K; Yasuda Y; Maeda K; Kurokawa K; van Ypersele de Strihou C
Kidney Int; 1997 Apr; 51(4):1170-81. PubMed ID: 9083283
[TBL] [Abstract][Full Text] [Related]
20. Efficient in vitro lowering of carbonyl stress by the glyoxalase system in conventional glucose peritoneal dialysis fluid.
Inagi R; Miyata T; Ueda Y; Yoshino A; Nangaku M; van Ypersele de Strihou C; Kurokawa K
Kidney Int; 2002 Aug; 62(2):679-87. PubMed ID: 12110033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]